Australia's Integrated Research hits 4-month high on robust FY outlook

Integrated Research

12/07/2023 02:02

** Shares of Australia's Integrated Research  IRI.AX  rise
as much as 17.3% to A$0.475, their highest since March 9
    ** The payments solutions provider expects to report
statutory EBITDA in the range of A$10 mln ($6.71 mln) to A$13
mln ($8.73 mln) for FY23, up 18%-53% from previous year
    ** Co expects statutory revenue in the range of A$67mln to 
A$70 mln in FY23, an increase of 7%-11% on the pcp
    ** Stock down 10% this year, as of last close 

    ($1 = 1.4896 Australian dollars)

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))